The National Institutes of Health has awarded a $55,000 grant to the Research Laboratories of Philadelphia’s Albert Einstein Medical Center; it was announced today.
The grant renews for an additional three years NIH support of an investigation into the ability of heparin–an anti-coagulant–to stimulate the body’s natural defense against certain diseases. The investigation is being conducted by Dr. Karl L. Roth, a Medical Center research scientist. Earlier NIH grants supporting the project totaled $110,000.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
